{"links": [{"source": 0, "target": "t8642", "value": "None"}, {"source": 0, "target": "t8605", "value": "None"}, {"source": 0, "target": "t8596", "value": "None"}, {"source": 0, "target": "t8580", "value": "None"}, {"source": 0, "target": "t8608", "value": "None"}, {"source": 0, "target": "t8646", "value": "None"}, {"source": 0, "target": "t8644", "value": "None"}, {"source": 0, "target": "t8606", "value": "None"}, {"source": 0, "target": "t8631", "value": "None"}, {"source": 0, "target": "t8623", "value": "None"}, {"source": 0, "target": "t8647", "value": "None"}, {"source": 0, "target": "t8619", "value": "None"}, {"source": 0, "target": "t8638", "value": "None"}, {"source": 0, "target": "t8609", "value": "None"}, {"source": 0, "target": "t8643", "value": "None"}, {"source": 0, "target": "t8611", "value": "None"}, {"source": 0, "target": "t8635", "value": "None"}, {"source": 0, "target": "t8584", "value": "None"}, {"source": 0, "target": "t8645", "value": "None"}, {"source": "t8596", "target": "t8604", "value": "None"}, {"source": "t8596", "target": "t8597", "value": "None"}, {"source": "t8580", "target": "t8581", "value": "None"}, {"source": "t8608", "target": "t8610", "value": "None"}, {"source": "t8646", "target": "t8648", "value": "None"}, {"source": "t8606", "target": "t8607", "value": "None"}, {"source": "t8606", "target": "d346", "value": "None"}, {"source": "t8623", "target": "t8632", "value": "None"}, {"source": "t8623", "target": "t8634", "value": "None"}, {"source": "t8623", "target": "t8633", "value": "None"}, {"source": "t8623", "target": "t8624", "value": "None"}, {"source": "t8647", "target": "t8648", "value": "None"}, {"source": "t8638", "target": "t8639", "value": "None"}, {"source": "t8609", "target": "t8610", "value": "None"}, {"source": "t8643", "target": "d346", "value": "None"}, {"source": "t8611", "target": "t8620", "value": "None"}, {"source": "t8611", "target": "t8612", "value": "None"}, {"source": "t8611", "target": "t8621", "value": "None"}, {"source": "t8611", "target": "t8622", "value": "None"}, {"source": "t8635", "target": "t8636", "value": "None"}, {"source": "t8635", "target": "t8637", "value": "None"}, {"source": "t8584", "target": "t8585", "value": "None"}, {"source": "t8645", "target": "t8648", "value": "None"}, {"source": "t8604", "target": "d341", "value": "None"}, {"source": "t8604", "target": "d15", "value": "None"}, {"source": "t8604", "target": "d372", "value": "None"}, {"source": "t8597", "target": "t8598", "value": "None"}, {"source": "t8581", "target": "t8583", "value": "None"}, {"source": "t8581", "target": "t8582", "value": "None"}, {"source": "t8610", "target": "d263", "value": "None"}, {"source": "t8610", "target": "d37", "value": "None"}, {"source": "t8648", "target": "t8649", "value": "None"}, {"source": "t8648", "target": "t8650", "value": "None"}, {"source": "t8607", "target": "t8610", "value": "None"}, {"source": "t8624", "target": "t8625", "value": "None"}, {"source": "t8639", "target": "t8641", "value": "None"}, {"source": "t8639", "target": "t8640", "value": "None"}, {"source": "t8612", "target": "t8613", "value": "None"}, {"source": "t8636", "target": "d346", "value": "None"}, {"source": "t8637", "target": "t8639", "value": "None"}, {"source": "t8637", "target": "d297", "value": "None"}, {"source": "t8637", "target": "d346", "value": "None"}, {"source": "t8585", "target": "t8594", "value": "None"}, {"source": "t8585", "target": "t8586", "value": "None"}, {"source": "t8585", "target": "t8595", "value": "None"}, {"source": "t8598", "target": "t8600", "value": "None"}, {"source": "t8598", "target": "t8599", "value": "None"}, {"source": "t8649", "target": "d263", "value": "None"}, {"source": "t8650", "target": "d263", "value": "None"}, {"source": "t8625", "target": "t8626", "value": "None"}, {"source": "t8641", "target": "d263", "value": "None"}, {"source": "t8641", "target": "d166", "value": "None"}, {"source": "t8640", "target": "d235", "value": "None"}, {"source": "t8613", "target": "t8614", "value": "None"}, {"source": "t8586", "target": "t8587", "value": "None"}, {"source": "t8600", "target": "t8601", "value": "None"}, {"source": "t8599", "target": "t8602", "value": "None"}, {"source": "t8626", "target": "t8627", "value": "None"}, {"source": "t8614", "target": "t8615", "value": "None"}, {"source": "t8587", "target": "t8588", "value": "None"}, {"source": "t8587", "target": "t8589", "value": "None"}, {"source": "t8601", "target": "t8602", "value": "None"}, {"source": "t8602", "target": "t8603", "value": "None"}, {"source": "t8627", "target": "t8628", "value": "None"}, {"source": "t8615", "target": "t8616", "value": "None"}, {"source": "t8588", "target": "t8589", "value": "None"}, {"source": "t8589", "target": "t8592", "value": "None"}, {"source": "t8589", "target": "t8590", "value": "None"}, {"source": "t8628", "target": "t8629", "value": "None"}, {"source": "t8628", "target": "t8630", "value": "None"}, {"source": "t8616", "target": "t8617", "value": "None"}, {"source": "t8616", "target": "t8618", "value": "None"}, {"source": "t8592", "target": "t8593", "value": "None"}, {"source": "t8590", "target": "t8591", "value": "None"}], "nodes": [{"category": "disease", "id": 0, "name": "Respiratory_infections", "x": "250", "y": "350", "fixed": "true", "draggable": "true", "value": {"name": "Respiratory_infections"}}, {"category": "treatment", "id": "t8642", "name": "person presenting with symptoms or signs of acute sore throat", "draggable": "true", "value": {"name": "person presenting with symptoms or signs of acute sore throat", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person presenting with symptoms or signs of acute sore throat", "drug": {}}}, {"category": "treatment", "id": "t8605", "name": "child or young person presenting with symptoms of acute otitis media", "draggable": "true", "value": {"name": "child or young person presenting with symptoms of acute otitis media", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:child or young person presenting with symptoms of acute otitis media", "drug": {}}}, {"category": "treatment", "id": "t8596", "name": "management in hospital", "draggable": "true", "value": {"name": "management in hospital", "type": "treatment related", "time": "", "intention": "", "description": "title:management in hospital", "drug": {}}}, {"category": "treatment", "id": "t8580", "name": "child presents with suspected bronchiolitis", "draggable": "true", "value": {"name": "child presents with suspected bronchiolitis", "type": "treatment related", "time": "", "intention": "", "description": "title:child presents with suspected bronchiolitis", "drug": {}}}, {"category": "treatment", "id": "t8608", "name": "more likely to benefit from antibiotics (under 18s with otorrhoea or under 2s with infection in both ears)", "draggable": "true", "value": {"name": "more likely to benefit from antibiotics (under 18s with otorrhoea or under 2s with infection in both ears)", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:more likely to benefit from antibiotics (under 18s with otorrhoea or under 2s with infection in both ears)head:More likely to benefit from antibiotics (under 18s with otorrhoea or under 2s with infection in both ears)Consider no antibiotic prescription with advice (see less likely to benefit from antibiotics), a back-up antibiotic prescription with advice (see less likely to benefit from antibiotics) or an immediate antibiotic prescription (see choice of antibiotic), taking account of: evidence that acute complications such as mastoiditis are rare with or without antibiotics possible adverse effects of antibiotics, particularly diarrhoea and nausea.When an immediate antibiotic prescription is given, as well as the general advice in assessment, advice and self-care, give advice about seeking medical help if symptoms worsen rapidly or significantly, or the child or young person becomes systemically very unwell.subhead:Why we made the recommendationsSee information on no antibiotics for acute otitis media, back-up antibiotics for acute otitis media and choice of antibiotic for acute otitis media.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG91", "drug": {}}}, {"category": "treatment", "id": "t8646", "name": "person most likely to benefit from an antibiotic (feverpain score of 4 or 5, or centor score of 3 or 4)", "draggable": "true", "value": {"name": "person most likely to benefit from an antibiotic (feverpain score of 4 or 5, or centor score of 3 or 4)", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person most likely to benefit from an antibiotic (feverpain score of 4 or 5, or centor score of 3 or 4)head:Person most likely to benefit from an antibiotic (FeverPAIN score of 4 or 5, or Centor score of 3 or 4)Consider an immediate antibiotic prescription (see the recommendations on choice of antibiotic for children and young people or adults), or a back-up antibiotic prescription with advice (see person more likely to benefit from an antibiotic (FeverPAIN score of 2 or 3)), taking account of: the unlikely event of complications if antibiotics are withheld possible adverse effects, particularly diarrhoea and nausea.When an immediate antibiotic prescription is given, as well as the general advice in assessment, advice and self-care, give advice about seeking medical help if symptoms worsen rapidly or significantly or the person becomes systemically very unwell.See FeverPAIN criteria and Centor criteria. subhead:Why we made the recommendationsSee information on no antibiotics, back-up antibiotics and identifying people more likely to benefit from antibiotics and antibiotic choice, dose and frequency of dosing.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG84", "drug": {}}}, {"category": "treatment", "id": "t8644", "name": "person unlikely to benefit from an antibiotic (feverpain score of 0 or 1, or centor score of 0, 1 or 2)", "draggable": "true", "value": {"name": "person unlikely to benefit from an antibiotic (feverpain score of 0 or 1, or centor score of 0, 1 or 2)", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person unlikely to benefit from an antibiotic (feverpain score of 0 or 1, or centor score of 0, 1 or 2)head:Person unlikely to benefit from an antibiotic (FeverPAIN score of 0 or 1, or Centor score of 0, 1 or 2)Do not offer an antibiotic prescription. As well as the general advice in assessment, advice and self-care, give advice about: an antibiotic not being needed seeking medical help if symptoms worsen rapidly or significantly, do not start to improve after 1 week, or the person becomes systemically very unwell.See FeverPAIN criteria and Centor criteria. subhead:Why we made the recommendationsSee information on no antibiotics, back-up antibiotics and identifying people more likely to benefit from antibiotics.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG84", "drug": {}}}, {"category": "treatment", "id": "t8606", "name": "assessment, advice and self care", "draggable": "true", "value": {"name": "assessment, advice and self care", "type": "treatment related", "time": "", "intention": "ibuprofen\nwhen used for inflammatory diseases, pain, dysmenorrhea, or fever, consider potential benefits and risks of ibuprofen therapy as well as alternative therapies before initiating therapy with the drug.192 use lowest effective dosage and shortest duration of therapy consistent with the patient\u2019s treatment goals.192\noral ibuprofen used for relief of mild to moderate pain in adults and children; iv ibuprofen used in adults for relief of mild to moderate pain and, in conjunction with opiates, for relief of moderate to severe pain.100 106 210\nnsaias may diminish cardiovascular effects of diuretics, ace inhibitors, or angiotensin ii receptor antagonists used to treat heart failure or edema.508 (see specific drugs under interactions.)\nwhen used for self-medication, importance of reading the product labeling.164 194\nwhen used for self-medication, importance of using the lowest effective dosage and of not exceeding the recommended dosage or duration of therapy.194 195\nwhen used for self medication, importance of reviewing the warning information provided by the manufacturer.164 194", "description": "title:assessment, advice and self-carehead:Assessment, advice and self-careBe aware that: acute otitis media is a self-limiting infection that mainly affects children  acute otitis media can be caused by viruses and bacteria, and it is difficult to distinguish between these (both are often present at the same time) symptoms last for about 3 days, but can last for up to 1 week most children and young people get better within 3 days without antibiotics complications such as mastoiditis are rare. NICE has produced a 2-page visual summary on otitis media (acute): antimicrobial prescribing.subhead:AssessmentAssess and manage children under 5 who present with fever as outlined in NICE s recommendations on fever in under 5s.Reassess at any time if symptoms worsen rapidly or significantly, taking account of: alternative diagnoses, such as otitis media with effusion (glue ear) (see what NICE says on surgical management of otitis media with effusion in children) any symptoms or signs suggesting a more serious illness or condition previous antibiotic use, which may lead to resistant organisms.NICE has published a clinical knowledge summary on otitis media \u2013 acute. This practical resource is for primary care professionals (it is not formal NICE guidance). subhead:AdviceGive advice about: the usual course of acute otitis media (about 3 days, can be up to 1 week) managing symptoms, including pain, with self-care.subhead:Self-careOffer regular doses of paracetamol or ibuprofen for pain, using the right dose for the age or weight of the child at the right time, and maximum doses for severe pain.Explain that evidence suggests decongestants or antihistamines do not help symptoms. See why we made the recommendations on self-care for acute otitis media.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG91", "drug": {}}}, {"category": "treatment", "id": "t8631", "name": "sore throat (including pharyngitis and tonsillitis)", "draggable": "true", "value": {"name": "sore throat (including pharyngitis and tonsillitis)", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:sore throat (including pharyngitis and tonsillitis)", "drug": {}}}, {"category": "treatment", "id": "t8623", "name": "person presenting with symptoms of a respiratory tract infection", "draggable": "true", "value": {"name": "person presenting with symptoms of a respiratory tract infection", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person presenting with symptoms of a respiratory tract infection", "drug": {}}}, {"category": "treatment", "id": "t8647", "name": "person who is systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high risk of complications", "draggable": "true", "value": {"name": "person who is systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high risk of complications", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person who is systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high-risk of complicationshead:Person who is systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high-risk of complicationsOffer an immediate antibiotic prescription (see the recommendations on choice of antibiotic for children and young people or adults) with advice (see person most likely to benefit from an antibiotic (FeverPAIN score of 4 or 5, or Centor score of 3 or 4)) or further appropriate investigation and management.Refer people to hospital if they have acute sore throat associated with any of the following: a severe systemic infection (see NICE s recommendations on sepsis) severe suppurative complications (such as quinsy [peri-tonsillar abscess] or cellulitis, parapharyngeal abscess or retropharyngeal abscess or Lemierre syndrome). subhead:Why we made the recommendationsSee information on antibiotic choice, dose and frequency of dosing.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG84", "drug": {}}}, {"category": "treatment", "id": "t8619", "name": "sore throat (including pharyngitis and tonsillitis)", "draggable": "true", "value": {"name": "sore throat (including pharyngitis and tonsillitis)", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:sore throat (including pharyngitis and tonsillitis)", "drug": {}}}, {"category": "treatment", "id": "t8638", "name": "systemically very unwell, symptoms and signs of a more serious illness or condition, or at high risk of complications", "draggable": "true", "value": {"name": "systemically very unwell, symptoms and signs of a more serious illness or condition, or at high risk of complications", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:systemically very unwell, symptoms and signs of a more serious illness or condition, or at high-risk of complicationshead:Systemically very unwell, symptoms and signs of a more serious illness or condition, or at high-risk of complicationsOffer an immediate antibiotic prescription (see the recommendations on choice of antibiotic for children and young people or adults) or further appropriate investigation and management in line with NICE s recommendations on when to prescribe antibiotics immediately for self-limiting respiratory tract infections.Refer people to hospital if they have symptoms and signs of acute sinusitis associated with any of the following: a severe systemic infection (see what NICE says on sepsis) intraorbital or periorbital complications, including periorbital oedema or cellulitis, a displaced eyeball, double vision, ophthalmoplegia, or newly reduced visual acuity intracranial complications, including swelling over the frontal bone, symptoms or signs of meningitis, severe frontal headache, or focal neurological signs.NICE has produced a 2-page visual summary on sinusitis (acute): antimicrobial prescribing.subhead:Why we made the recommendationsSee information on choice of antibiotic.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG79", "drug": {}}}, {"category": "treatment", "id": "t8609", "name": "systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high risk of complications", "draggable": "true", "value": {"name": "systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high risk of complications", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high-risk of complicationshead:Systemically very unwell, has symptoms and signs of a more serious illness or condition, or is at high-risk of complicationsOffer an immediate antibiotic prescription (see choice of antibiotic) with advice (see more likely to benefit from antibiotics) or further appropriate investigation and management.Refer children and young people to hospital if they have acute otitis media associated with: a severe systemic infection (see NICE s recommendations on sepsis) acute complications, including mastoiditis, meningitis (see NICE s recommendations on bacterial meningitis and meningococcal septicaemia), intracranial abscess, sinus thrombosis or facial nerve paralysis.subhead:Why we made the recommendationsSee information on choice of antibiotic for acute otitis media.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG91", "drug": {}}}, {"category": "treatment", "id": "t8643", "name": "assessment, advice and self care", "draggable": "true", "value": {"name": "assessment, advice and self care", "type": "treatment related", "time": "", "intention": "ibuprofen\nwhen used for inflammatory diseases, pain, dysmenorrhea, or fever, consider potential benefits and risks of ibuprofen therapy as well as alternative therapies before initiating therapy with the drug.192 use lowest effective dosage and shortest duration of therapy consistent with the patient\u2019s treatment goals.192\noral ibuprofen used for relief of mild to moderate pain in adults and children; iv ibuprofen used in adults for relief of mild to moderate pain and, in conjunction with opiates, for relief of moderate to severe pain.100 106 210\nnsaias may diminish cardiovascular effects of diuretics, ace inhibitors, or angiotensin ii receptor antagonists used to treat heart failure or edema.508 (see specific drugs under interactions.)\nwhen used for self-medication, importance of reading the product labeling.164 194\nwhen used for self-medication, importance of using the lowest effective dosage and of not exceeding the recommended dosage or duration of therapy.194 195\nwhen used for self medication, importance of reviewing the warning information provided by the manufacturer.164 194", "description": "title:assessment, advice and self-carehead:Assessment, advice and self-careBe aware that: acute sore throat (including pharyngitis and tonsillitis) is self-limiting and often triggered by a viral infection of the upper respiratory tract symptoms can last for around 1 week, but most people will get better within this time without antibiotics, regardless of cause (bacteria or virus).Assess and manage children under 5 who present with fever as outlined in NICE s recommendations on fever in under 5s.Use FeverPAIN criteria or Centor criteria to identify people who are more likely to benefit from an antibiotic and manage in line with recommendations below.Give advice about: the usual course of acute sore throat (can last around 1 week) managing symptoms, including pain, fever and dehydration, with self-care (see the recommendations on self-care below).Reassess at any time if symptoms worsen rapidly or significantly, taking account of: alternative diagnoses such as scarlet fever or glandular fever any symptoms or signs suggesting a more serious illness or condition previous antibiotic use, which may lead to resistant organisms.NICE has produced a 2-page visual summary on sore throat (acute): antimicrobial prescribing.subhead:Self-careConsider paracetamol for pain or fever, or if preferred and suitable, ibuprofen. Advise about the adequate intake of fluids.Explain that some adults may wish to try medicated lozenges containing either a local anaesthetic, an NSAID or an antiseptic. However, they may only help to reduce pain by a small amount. Be aware that no evidence was found on non-medicated lozenges, mouthwashes, or local anaesthetic mouth spray used on its own. See why we made the recommendations on self-care for acute sore throat.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG84", "drug": {}}}, {"category": "treatment", "id": "t8611", "name": "person presenting with symptoms of a respiratory tract infection", "draggable": "true", "value": {"name": "person presenting with symptoms of a respiratory tract infection", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person presenting with symptoms of a respiratory tract infection", "drug": {}}}, {"category": "treatment", "id": "t8635", "name": "person presenting with symptoms of sinusitis", "draggable": "true", "value": {"name": "person presenting with symptoms of sinusitis", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person presenting with symptoms of sinusitis", "drug": {}}}, {"category": "treatment", "id": "t8584", "name": "child presents with suspected bronchiolitis", "draggable": "true", "value": {"name": "child presents with suspected bronchiolitis", "type": "treatment related", "time": "", "intention": "", "description": "title:child presents with suspected bronchiolitis", "drug": {}}}, {"category": "treatment", "id": "t8645", "name": "person more likely to benefit from an antibiotic (feverpain score of 2 or 3)", "draggable": "true", "value": {"name": "person more likely to benefit from an antibiotic (feverpain score of 2 or 3)", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person more likely to benefit from an antibiotic (feverpain score of 2 or 3)head:Person more likely to benefit from an antibiotic (FeverPAIN score of 2 or 3)Consider no antibiotic prescription with advice (see person unlikely to benefit from an antibiotic (FeverPAIN score of 0 or 1, or Centor score of 0, 1 or 2)) or a back-up antibiotic prescription (see the recommendations on choice of antibiotic for children and young people or adults), taking account of: evidence that antibiotics make little difference to how long symptoms last (on average, they shorten symptoms by about 16 hours) evidence that most people feel better after 1 week, with or without antibiotics the unlikely event of complications if antibiotics are withheld possible adverse effects, particularly diarrhoea and nausea.When a back-up antibiotic prescription is given, as well as the general advice in assessment, advice and self-care, give advice about: an antibiotic not being needed immediately  using the back-up prescription if symptoms do not start to improve within 3 to 5 days or if they worsen rapidly or significantly at any time seeking medical help if symptoms worsen rapidly or significantly or the person becomes systemically very unwell.See FeverPAIN criteria. subhead:Why we made the recommendationsSee information on no antibiotics, back-up antibiotics and identifying people more likely to benefit from antibiotics.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG84", "drug": {}}}, {"category": "treatment", "id": "t8604", "name": "treatments that should not be used", "draggable": "true", "value": {"name": "treatments that should not be used", "type": "treatment related", "time": "", "intention": "hypertonic saline\n", "description": "title:treatments that should not be usedhead:Treatments that should not be usedDo not use any of the following to treat bronchiolitis in children: antibiotics hypertonic saline adrenaline (nebulised) salbutamol montelukast ipratropium bromide systemic or inhaled corticosteroids a combination of systemic corticosteroids and nebulised adrenaline.subhead:Chest physiotherapyDo not perform chest physiotherapy on children with bronchiolitis who do not have relevant comorbidities (for example spinal muscular atrophy, severe tracheomalacia).Consider requesting a chest physiotherapy assessment in children who have relevant comorbidities (for example spinal muscular atrophy, severe tracheomalacia) when there may be additional difficulty clearing secretions.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.1Antibiotic use2Bronchiolitis managementSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8597", "name": "airway suction", "draggable": "true", "value": {"name": "airway suction", "type": "treatment related", "time": "", "intention": "", "description": "title:airway suctionhead:Airway suctionDo not routinely perform upper airway suctioning in children with bronchiolitis.Consider upper airway suctioning in children who have respiratory distress or feeding difficulties because of upper airway secretions.Perform upper airway suctioning in children with bronchiolitis presenting with apnoea even if there are no obvious upper airway secretions.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8581", "name": "diagnosing bronchiolitis in children", "draggable": "true", "value": {"name": "diagnosing bronchiolitis in children", "type": "treatment related", "time": "", "intention": "", "description": "title:diagnosing bronchiolitis in children", "drug": {}}}, {"category": "treatment", "id": "t8610", "name": "choice of antibiotic", "draggable": "true", "value": {"name": "choice of antibiotic", "type": "disease name and patient related", "time": "", "intention": "erythromycin\nhas been used for treatment of intestinal amebiasis caused by entamoeba histolytica.242 262 263 268 f erythromycin generally not recommended for treatment of amebiasis; regimen of choice for intestinal amebiasis is metronidazole or tinidazole followed by a luminal amebicide such as iodoquinol or paromomycin.259 311\niv erythromycin lactobionate followed by oral erythromycin has been used for treatment of pid) caused by n. gonorrhoeae,242 262 263 c f but erythromycins are not included in current cdc recommendations for treatment of pid.228\nerythromycin (lactobionate): 15\u201320 mg/kg daily.c dosage up to 4 g daily may be used for severe infections.c\nerythromycin (ethylsuccinate): 400 mg every 6 hours.268 f dosage up to 4 g daily may be used for severe infections.268 f", "description": "title:choice of antibiotichead:Choice of antibioticFollow the table below when prescribing an antibiotic for children and young people with acute otitis media. Antibiotic1 Dosage and course length2 First choice Amoxicillin 1 to 11 months, 125 mg three times a day for 5 to 7 days1 to 4 years, 250 mg three times a day for 5 to 7 days5 to 17 years, 500 mg three times a day for 5 to 7 days Alternative first choices for penicillin allergy or intolerance3Clarithromycin 1 month to 11 years: Under 8 kg, 7.5 mg/kg twice a day for 5 to 7 days 8 to 11 kg, 62.5 mg twice a day for 5 to 7 days 12 to 19 kg, 125 mg twice a day for 5 to 7 days 20 to 29 kg, 187.5 mg twice a day for 5 to 7 days 30 to 40 kg, 250 mg twice a day for 5 to 7 days12 to 17 years, 250 mg to 500 mg twice a day for 5 to 7 days Erythromycin 1 month to 1 year, 125 mg four times a day or 250 mg twice a day for 5 to 7 days2 to 7 years, 250 mg four times a day or 500 mg twice a day for 5 to 7 days8 to 17 years, 250 mg to 500 mg four times a day or 500 mg to 1,000 mg twice a day for 5 to 7 days Second choice (worsening symptoms on first choice taken for at least 2 to 3 days)Co-amoxiclav 1 to 11 months, 0.25 ml/kg of 125/31 suspension three times a day for 5 to 7 days1 to 5 years, 5 ml of 125/31 suspension three times a day or 0.25 ml/kg of 125/31 suspension three times a day for 5 to 7 days6 to 11 years, 5 ml of 250/62 suspension three times a day or 0.15 ml/kg of 250/62 suspension three times a day for 5 to 7 days12 to 17 years, 250/125 mg or 500/125 mg three times a day for 5 to 7 days Alternative second choice for penicillin allergy or intoleranceConsult local microbiologist 1 See BNF for children for appropriate use and dosing in specific populations, for example, hepatic impairment and renal impairment.2 The age bands apply to children of average size and, in practice, the prescriber will use the age bands in conjunction with other factors such as the severity of the condition and the child s size in relation to the average size of children of the same age. Doses given are by mouth using immediate-release medicines, unless otherwise stated.3 Erythromycin is preferred in young women who are pregnant. See what NICE says on medicines optimisation.subhead:Why we made the recommendationsSee information on choice of antibiotic for acute otitis media and antibiotic course length for acute otitis media.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG91", "drug": {}}}, {"category": "treatment", "id": "t8648", "name": "choice of antibiotic", "draggable": "true", "value": {"name": "choice of antibiotic", "type": "treatment related", "time": "", "intention": "", "description": "title:choice of antibiotic", "drug": {}}}, {"category": "treatment", "id": "t8607", "name": "less likely to benefit from antibiotics", "draggable": "true", "value": {"name": "less likely to benefit from antibiotics", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:less likely to benefit from antibioticshead:Less likely to benefit from antibioticsConsider no antibiotic prescription or a back-up antibiotic prescription (see choice of antibiotic), taking account of: evidence that antibiotics make little difference to symptoms (no improvement in pain at 24 hours, and after that the number of children improving is similar to the number with adverse effects) evidence that antibiotics make little difference to the development of common complications (such as short-term hearing loss [measured by tympanometry], perforated eardrum or recurrent infection) evidence that acute complications such as mastoiditis are rare with or without antibiotics possible adverse effects of antibiotics, particularly diarrhoea and nausea.When no antibiotic prescription is given, as well as the general advice in assessment, advice and self-care, give advice about:  an antibiotic not being needed seeking medical help if symptoms worsen rapidly or significantly, do not start to improve after 3 days, or the child or young person becomes systemically very unwell.When a back-up antibiotic prescription is given, as well as the general advice in assessment, advice and self-care, give advice about: an antibiotic not being needed immediately using the back-up prescription if symptoms do not start to improve within 3 days or if they worsen rapidly or significantly at any time seeking medical help if symptoms worsen rapidly or significantly, or the child or young person becomes systemically very unwell.subhead:Why we made the recommendationsSee information on no antibiotics for acute otitis media and back-up antibiotics for acute otitis media.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG91", "drug": {}}}, {"category": "treatment", "id": "t8632", "name": "antimicrobial prescribing for common infections", "draggable": "true", "value": {"name": "antimicrobial prescribing for common infections", "type": "treatment related", "time": "", "intention": "", "description": "title:antimicrobial prescribing for common infections", "drug": {}}}, {"category": "treatment", "id": "t8634", "name": "patient experience in adult nhs services", "draggable": "true", "value": {"name": "patient experience in adult nhs services", "type": "treatment related", "time": "", "intention": "", "description": "title:patient experience in adult nhs services", "drug": {}}}, {"category": "treatment", "id": "t8633", "name": "antimicrobial stewardship", "draggable": "true", "value": {"name": "antimicrobial stewardship", "type": "treatment related", "time": "", "intention": "", "description": "title:antimicrobial stewardship", "drug": {}}}, {"category": "treatment", "id": "t8624", "name": "clinical assessment", "draggable": "true", "value": {"name": "clinical assessment", "type": "treatment related", "time": "", "intention": "", "description": "title:clinical assessmenthead:Clinical assessmentAt the first face-to-face contact in primary care, including walk-in centres and emergency departments, adults and children (3 months and older) presenting with a history suggestive of the following conditions should be offered a clinical assessment: acute otitis media acute sore throat/acute pharyngitis/acute tonsillitis common cold acute rhinosinusitis acute cough/acute bronchitis.The clinical assessment should include a history (presenting symptoms, use of over-the-counter or self medication, previous medical history, relevant risk factors, relevant comorbidities) and, if indicated, an examination to identify relevant clinical signs.For information about fever in children younger than 5 years, see what NICE says on fever in under 5s.NICE has published clinical knowledge summaries on: chest infections \u2013 adult common cold cough otitis media \u2013 acute sinusitis sore throat \u2013 acute.These practical resources are for primary care professionals (they are not formal NICE guidance).NICE has published medtech innovation briefings on:  FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary careAlere Afinion CRP for C-reactive protein testing in primary careQuikRead go for C-reactive protein testing in primary care.subhead:MeningitisIf meningitis is suspected, see what NICE says on bacterial meningitis and meningococcal septicaemia.subhead:PneumoniaIf pneumonia is suspected, see what NICE says on pneumonia.subhead:SepsisIf sepsis is suspected, see what NICE says on sepsis.subhead:TuberculosisIf tuberculosis is suspected, see what NICE says on tuberculosis.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8639", "name": "choice of antibiotic", "draggable": "true", "value": {"name": "choice of antibiotic", "type": "treatment related", "time": "", "intention": "", "description": "title:choice of antibiotic", "drug": {}}}, {"category": "treatment", "id": "t8620", "name": "antimicrobial prescribing for common infections", "draggable": "true", "value": {"name": "antimicrobial prescribing for common infections", "type": "treatment related", "time": "", "intention": "", "description": "title:antimicrobial prescribing for common infections", "drug": {}}}, {"category": "treatment", "id": "t8612", "name": "clinical assessment", "draggable": "true", "value": {"name": "clinical assessment", "type": "treatment related", "time": "", "intention": "", "description": "title:clinical assessmenthead:Clinical assessmentAt the first face-to-face contact in primary care, including walk-in centres and emergency departments, adults and children (3 months and older) presenting with a history suggestive of the following conditions should be offered a clinical assessment: acute otitis media acute sore throat/acute pharyngitis/acute tonsillitis common cold acute rhinosinusitis acute cough/acute bronchitis.The clinical assessment should include a history (presenting symptoms, use of over-the-counter or self medication, previous medical history, relevant risk factors, relevant comorbidities) and, if indicated, an examination to identify relevant clinical signs.For information about fever in children younger than 5 years, see what NICE says on fever in under 5s.NICE has published clinical knowledge summaries on: chest infections \u2013 adult common cold cough otitis media \u2013 acute sinusitis sore throat \u2013 acute.These practical resources are for primary care professionals (they are not formal NICE guidance).NICE has published medtech innovation briefings on:  FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary careAlere Afinion CRP for C-reactive protein testing in primary careQuikRead go for C-reactive protein testing in primary care.subhead:MeningitisIf meningitis is suspected, see what NICE says on bacterial meningitis and meningococcal septicaemia.subhead:PneumoniaIf pneumonia is suspected, see what NICE says on pneumonia.subhead:SepsisIf sepsis is suspected, see what NICE says on sepsis.subhead:TuberculosisIf tuberculosis is suspected, see what NICE says on tuberculosis.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8621", "name": "antimicrobial stewardship", "draggable": "true", "value": {"name": "antimicrobial stewardship", "type": "treatment related", "time": "", "intention": "", "description": "title:antimicrobial stewardship", "drug": {}}}, {"category": "treatment", "id": "t8622", "name": "patient experience in adult nhs services", "draggable": "true", "value": {"name": "patient experience in adult nhs services", "type": "treatment related", "time": "", "intention": "", "description": "title:patient experience in adult nhs services", "drug": {}}}, {"category": "treatment", "id": "t8636", "name": "symptoms for around 10 days or less", "draggable": "true", "value": {"name": "symptoms for around 10 days or less", "type": "treatment related", "time": "", "intention": "ibuprofen\nwhen used for inflammatory diseases, pain, dysmenorrhea, or fever, consider potential benefits and risks of ibuprofen therapy as well as alternative therapies before initiating therapy with the drug.192 use lowest effective dosage and shortest duration of therapy consistent with the patient\u2019s treatment goals.192\noral ibuprofen used for relief of mild to moderate pain in adults and children; iv ibuprofen used in adults for relief of mild to moderate pain and, in conjunction with opiates, for relief of moderate to severe pain.100 106 210\nnsaias may diminish cardiovascular effects of diuretics, ace inhibitors, or angiotensin ii receptor antagonists used to treat heart failure or edema.508 (see specific drugs under interactions.)\nwhen used for self-medication, importance of reading the product labeling.164 194\nwhen used for self-medication, importance of using the lowest effective dosage and of not exceeding the recommended dosage or duration of therapy.194 195\nwhen used for self medication, importance of reviewing the warning information provided by the manufacturer.164 194", "description": "title:symptoms for around 10 days or lesshead:Symptoms for around 10 days or lessDo not offer an antibiotic prescription. Give advice about: the usual course of acute sinusitis (2 to 3 weeks)  an antibiotic not being needed managing symptoms, including fever, with self-care (see the recommendations below on self-care) seeking medical help if symptoms worsen rapidly or significantly, do not improve after 3 weeks, or they become systemically very unwell.Reassess if symptoms worsen rapidly or significantly, taking account of:  alternative diagnoses such as a dental infection any symptoms or signs suggesting a more serious illness or condition.See symptoms and signs of acute sinusitis. NICE has produced a 2-page visual summary on sinusitis (acute): antimicrobial prescribing.subhead:Self-careConsider paracetamol or ibuprofen for pain or fever (assess and manage children aged under 5 who present with fever as outlined in NICE s recommendations on fever in under 5s).Explain that some people may wish to try nasal saline or nasal decongestants, although there is not enough evidence to show that they help to relieve nasal congestion.Explain that no evidence was found for using oral decongestants, antihistamines, mucolytics, steam inhalation, or warm face packs.subhead:Why we made the recommendationsSee information on no antibiotic and self-care.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG79", "drug": {}}}, {"category": "treatment", "id": "t8637", "name": "symptoms for around 10 days or more with no improvement", "draggable": "true", "value": {"name": "symptoms for around 10 days or more with no improvement", "type": "treatment related", "time": "", "intention": "fluticasone\nthis medication should not be used for any disorder other than that for which it was prescribed.", "description": "title:symptoms for around 10 days or more with no improvementhead:Symptoms for around 10 days or more with no improvementConsider prescribing a high-dose nasal corticosteroidHigh-dose nasal corticosteroids used in the studies were mometasone 200 micrograms twice a day and fluticasone 110 micrograms twice a day. Nasal corticosteroids are not licensed for treating acute sinusitis, so use for this indication would be off label. The prescriber should follow relevant professional guidance, taking full responsibility for the decision. Informed consent should be obtained and documented. See the General Medical Council s Good practice in prescribing and managing medicines and devices for further information. for 14 days for adults and children aged 12 years and over, being aware that nasal corticosteroids:  may improve symptoms but are not likely to affect how long they last could cause systemic effects, particularly in people already taking another corticosteroid may be difficult for people to use correctly.Consider no antibiotic prescription or a back-up antibiotic prescription (see the recommendations on choice of antibiotic for children and young people or adults), taking account of: evidence that antibiotics make little difference to how long symptoms last, or the proportion of people with improved symptoms withholding antibiotics is unlikely to lead to complications possible adverse effects, particularly diarrhoea and nausea factors that might make a bacterial cause more likely (see symptoms and signs of acute sinusitis).When a back-up antibiotic prescription is given, give verbal and written advice about: managing symptoms, including fever, with self-care (see the recommendations below on self-care) an antibiotic not being needed immediately using the back-up prescription if symptoms do not improve within 7 days or if they worsen rapidly or significantly at any time seeking medical help if symptoms worsen rapidly or significantly despite taking the antibiotic, or the antibiotic has been stopped because it was not tolerated.Reassess if symptoms worsen rapidly or significantly despite taking treatment, taking account of:  alternative diagnoses such as a dental infection any signs or symptoms suggesting a more serious illness or condition previous antibiotic use, which may lead to resistant organisms.NICE has produced a 2-page visual summary on sinusitis (acute): antimicrobial prescribing.subhead:Self-careConsider paracetamol or ibuprofen for pain or fever (assess and manage children aged under 5 who present with fever as outlined in NICE s recommendations on fever in under 5s).Explain that some people may wish to try nasal saline or nasal decongestants, although there is not enough evidence to show that they help to relieve nasal congestion.Explain that no evidence was found for using oral decongestants, antihistamines, mucolytics, steam inhalation, or warm face packs.subhead:Why we made the recommendationsSee information on nasal corticosteroids, back-up antibiotics and self-care.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG79", "drug": {}}}, {"category": "treatment", "id": "t8585", "name": "assessment and diagnosis", "draggable": "true", "value": {"name": "assessment and diagnosis", "type": "treatment related", "time": "", "intention": "", "description": "title:assessment and diagnosishead:Assessment and diagnosisWhen diagnosing bronchiolitis, take into account that it occurs in children under 2 years of age and most commonly in the first year of life, peaking between 3 and 6 months.When diagnosing bronchiolitis, take into account that symptoms usually peak between 3 and 5 days, and that cough resolves in 90% of infants within 3 weeks.Diagnose bronchiolitis if the child has a coryzal prodrome lasting 1 to 3 days, followed by: persistent cough and either tachypnoea or chest recession (or both) and either wheeze or crackles on chest auscultation (or both).When diagnosing bronchiolitis, take into account that the following symptoms are common in children with this disease: fever (in around 30% of cases, usually of less than 39\u00b0C) poor feeding (typically after 3 to 5 days of illness).When diagnosing bronchiolitis, take into account that young infants with this disease (in particular those under 6 weeks of age) may present with apnoea without other clinical signs.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8598", "name": "oxygen supplementation", "draggable": "true", "value": {"name": "oxygen supplementation", "type": "treatment related", "time": "", "intention": "", "description": "title:oxygen supplementationhead:Oxygen supplementationGive oxygen supplementation to children with bronchiolitis if their oxygen saturation is persistently less than 92%.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8583", "name": "management of bronchiolitis", "draggable": "true", "value": {"name": "management of bronchiolitis", "type": "treatment related", "time": "", "intention": "", "description": "title:management of bronchiolitis", "drug": {}}}, {"category": "treatment", "id": "t8582", "name": "safety information when looking after a child at home", "draggable": "true", "value": {"name": "safety information when looking after a child at home", "type": "treatment related", "time": "", "intention": "", "description": "title:safety information when looking after a child at homehead:Safety information when looking after a child at homeProvide key safety information for parents and carers to take away for reference for children who will be looked after at home. This should cover: how to recognise developing  red flag  symptoms: worsening work of breathing (for example grunting, nasal flaring, marked chest recession) fluid intake is 50\u201375% of normal or no wet nappy for 12 hours apnoea or cyanosis exhaustion (for example, not responding normally to social cues, wakes only with prolonged stimulation) that people should not smoke in the child s home because it increases the risk of more severe symptoms in bronchiolitis how to get immediate help from an appropriate professional if any red flag symptoms develop  arrangements for follow-up if necessary.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.3Key safety informationSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8649", "name": "children and young people", "draggable": "true", "value": {"name": "children and young people", "type": "disease name and patient related", "time": "", "intention": "erythromycin\nhas been used for treatment of intestinal amebiasis caused by entamoeba histolytica.242 262 263 268 f erythromycin generally not recommended for treatment of amebiasis; regimen of choice for intestinal amebiasis is metronidazole or tinidazole followed by a luminal amebicide such as iodoquinol or paromomycin.259 311\niv erythromycin lactobionate followed by oral erythromycin has been used for treatment of pid) caused by n. gonorrhoeae,242 262 263 c f but erythromycins are not included in current cdc recommendations for treatment of pid.228\nerythromycin (lactobionate): 15\u201320 mg/kg daily.c dosage up to 4 g daily may be used for severe infections.c\nerythromycin (ethylsuccinate): 400 mg every 6 hours.268 f dosage up to 4 g daily may be used for severe infections.268 f", "description": "title:children and young peoplehead:Children and young peopleWhen prescribing antibiotics for acute sore throat, follow the table below for children and young people under 18 years.Antibiotic1 Dosage and course length for children and young people2 First choice Phenoxymethylpenicillin 1 to 11 months, 62.5 mg four times a day or 125 mg twice a day for 5 to 10 days1 to 5 years, 125 mg four times a day or 250 mg twice a day for 5 to 10 days6 to 11 years, 250 mg four times a day or 500 mg twice a day for 5 to 10 days12 to 17 years, 500 mg four times a day or 1000 mg twice a day for 5 to 10 daysAlternative first choices for penicillin allergy or intolerance3Clarithromycin 1 month to 11 years:Under 8 kg, 7.5 mg/kg twice a day for 5 days8 to 11 kg, 62.5 mg twice a day for 5 days12 to 19 kg, 125 mg twice a day for 5 days20 to 29 kg, 187.5 mg twice a day for 5 days30 to 40 kg, 250 mg twice a day for 5 daysor 12 to 17 years, 250 mg to 500 mg twice a day for 5 days  Erythromycin 1 month to 1 year, 125 mg four times a day or 250 mg twice a day for 5 days2 to 7 years, 250 mg four times a day or 500 mg twice a day for 5 days8 to 17 years, 250 mg to 500 mg four times a day or 500 mg to 1000 mg twice a day for 5 days1 See BNF for children for appropriate use and dosing in specific populations, for example hepatic impairment and renal impairment.2 The age bands apply to children of average size and, in practice, the prescriber will use the age bands in conjunction with other factors such as the severity of the condition and the child s size in relation to the average size of children of the same age. Doses given are by mouth using immediate-release medicines, unless otherwise stated.3 Erythromycin is preferred in young women who are pregnant.See what NICE says on medicines optimisation.subhead:Why we made the recommendationsSee information on antibiotic choice, dose and frequency of dosing and antibiotic course length for acute sore throat.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG84", "drug": {}}}, {"category": "treatment", "id": "t8650", "name": "adults", "draggable": "true", "value": {"name": "adults", "type": "treatment related", "time": "", "intention": "erythromycin\nhas been used for treatment of intestinal amebiasis caused by entamoeba histolytica.242 262 263 268 f erythromycin generally not recommended for treatment of amebiasis; regimen of choice for intestinal amebiasis is metronidazole or tinidazole followed by a luminal amebicide such as iodoquinol or paromomycin.259 311\niv erythromycin lactobionate followed by oral erythromycin has been used for treatment of pid) caused by n. gonorrhoeae,242 262 263 c f but erythromycins are not included in current cdc recommendations for treatment of pid.228\nerythromycin (lactobionate): 15\u201320 mg/kg daily.c dosage up to 4 g daily may be used for severe infections.c\nerythromycin (ethylsuccinate): 400 mg every 6 hours.268 f dosage up to 4 g daily may be used for severe infections.268 f", "description": "title:adultshead:AdultsWhen prescribing antibiotics for acute sore throat, follow the table below for adults aged 18 years and over.Antibiotic1 Dosage and course length for adults2 First choice Phenoxymethylpenicillin 500 mg four times a day or 1000 mg twice a day for 5 to 10 days Alternative first choices for penicillin allergy or intolerance3Clarithromycin 250 mg to 500 mg twice a day for 5 days Erythromycin 250 mg to 500 mg four times a day or 500 mg to 1000 mg twice a day for 5 days1 See BNF for appropriate use and dosing in specific populations, for example, hepatic impairment, renal impairment, pregnancy and breast-feeding.2 Doses given are by mouth using immediate-release medicines, unless otherwise stated.3 Erythromycin is preferred in women who are pregnant.See what NICE says on medicines optimisation.subhead:Why we made the recommendationsSee information on antibiotic choice, dose and frequency of dosing and antibiotic course length for acute sore throat.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG84", "drug": {}}}, {"category": "treatment", "id": "t8625", "name": "when to prescribe antibiotics immediately", "draggable": "true", "value": {"name": "when to prescribe antibiotics immediately", "type": "treatment related", "time": "", "intention": "", "description": "title:when to prescribe antibiotics immediatelyhead:When to prescribe antibiotics immediatelyAn immediate antibiotic prescription and/or further appropriate investigation and management should only be offered to patients (both adults and children) in the following situations: if the patient is systemically very unwell if the patient has symptoms and signs suggestive of serious illness and/or complications (particularly pneumonia, mastoiditis, peritonsillar abscess, peritonsillar cellulitis, intraorbital and intracranial complications) if the patient is at high risk of serious complications because of pre-existing comorbidity. This includes patients with significant heart, lung, renal, liver or neuromuscular disease, immunosuppression, cystic fibrosis, and young children who were born prematurely if the patient is older than 65 years with acute cough and two or more of the following criteria, or older than 80 years with acute cough and one or more of the following criteria: hospitalisation in previous year type 1 or type 2 diabetes history of congestive heart failure current use of oral glucocorticoids.For these patients, the no antibiotic prescribing strategy and the delayed antibiotic prescribing strategy should not be considered.Depending on clinical assessment of severity, patients in the following subgroups can also be considered for an immediate antibiotic prescribing strategy (in addition to a no antibiotic or a delayed antibiotic prescribing strategy): bilateral acute otitis media in children younger than 2 years acute otitis media in children with otorrhoea acute sore throat/acute pharyngitis/acute tonsillitis when three or more Centor criteria are present.See what NICE says on pneumonia and medicines optimisation.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8641", "name": "adults", "draggable": "true", "value": {"name": "adults", "type": "disease name and patient related", "time": "", "intention": "clarithromycin\nclarithromycin is used to treat many different types of bacterial infections affecting the skin and respiratory system. clarithromycin is also used together with other medicines to treat stomach ulcers caused by helicobacter pylori.\nclarithromycin may also be used for purposes not listed in this medication guide.\ntell your doctor about all your current medicines and any you start or stop using. many drugs can interact with clarithromycin, and some drugs should not be used together.\nmany drugs can interact with clarithromycin, and some drugs should not be used together. this includes prescription and over-the-counter medicines, vitamins, and herbal products. not all possible interactions are listed in this medication guide. tell your doctor about all your current medicines and any medicine you start or stop using.\nwhat antibiotics are used to treat pneumonia?", "description": "title:adultshead:AdultsWhen prescribing antibiotics for acute sinusitis, follow the recommendations in the table below for adults aged 18 years and over.Antibiotic1 Dosage and course length for adults First choice Phenoxymethylpenicillin 500 mg four times a day for 5 days First choice if systemically very unwell, symptoms and signs of a more serious illness or condition, or at high-risk of complications Co-amoxiclav 500/125 mg three times a day for 5 days Alternative first choices for penicillin allergy or intoleranceDoxycycline 200 mg on first day, then 100 mg once a day for 4 days (5-day course in total) Clarithromycin 500 mg twice a day for 5 days Erythromycin (in pregnancy)250 mg to 500 mg four times a day or 500 mg to 1000 mg twice a day for 5 daysSecond choice (worsening symptoms on first choice taken for at least 2 to 3 days) Co-amoxiclav2 500/125 mg three times a day for 5 daysAlternative second choice for penicillin allergy or intolerance, or worsening symptoms on second choice taken for at least 2 to 3 daysConsult local microbiologist 1 See BNF for appropriate use and dosing in specific populations, for example, hepatic impairment, renal impairment, pregnancy and breast-feeding.2 If co-amoxiclav has been used as first choice, consult local microbiologist for advice on second choice. See what NICE says on medicines optimisation.subhead:Why we made the recommendationsSee information on choice of antibiotic and antibiotic course length.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG79", "drug": {}}}, {"category": "treatment", "id": "t8640", "name": "children and young people", "draggable": "true", "value": {"name": "children and young people", "type": "disease name and patient related", "time": "", "intention": "doxycycline\ndoxycycline 40-mg capsules are not to be used for the treatment or prevention of bacterial infections or to reduce or eliminate organisms associated with bacterial disease.1 the dosage regimen used for the treatment of rosacea results in doxycycline plasma concentrations that are too low for the treatment of bacterial infections.1", "description": "title:children and young peoplehead:Children and young peopleWhen prescribing antibiotics for acute sinusitis, follow the recommendations in the table below for children and young people under 18 years.Antibiotic1 Dosage and course length for children and young people2 First choice Phenoxymethylpenicillin 1 to 11 months, 62.5 mg four times a day for 5 days1 to 5 years, 125 mg four times a day for 5 days6 to 11 years, 250 mg four times a day for 5 days12 to 17 years, 500 mg four times a day for 5 daysFirst choice if systemically very unwell, symptoms and signs of a more serious illness or condition, or at high-risk of complications Co-amoxiclav 1 to 11 months, 0.25 ml/kg of 125/31 suspension three times a day for 5 days1 to 5 years, 5 ml of 125/31 suspension three times a day or 0.25 ml/kg of 125/31 suspension three times a day for 5 days6 to 11 years, 5 ml of 250/62 suspension three times a day or 0.15 ml/kg of 250/62 suspension three times a day for 5 days12 to 17 years, 250/125 mg three times a day or 500/125 mg three times a day for 5 daysAlternative first choice for penicillin allergy or intoleranceClarithromycin Under 8 kg, 7.5 mg/kg twice a day for 5 days8 to 11 kg, 62.5 mg twice a day for 5 days12 to 19 kg, 125 mg twice a day for 5 days20 to 29 kg, 187.5 mg twice a day for 5 days 30 to 40 kg, 250 mg twice a day for 5 days12 to 17 years, 250 mg twice a day or 500 mg twice a day for 5 days Doxycycline3 12 to 17 years, 200 mg on first day, then 100 mg once a day for 4 days (5-day course in total)Second choice (worsening symptoms on first choice taken for at least 2 to 3 days) Co-amoxiclav4 As aboveAlternative second choice for penicillin allergy or intolerance, or worsening symptoms on second choice taken for at least 2 to 3 daysConsult local microbiologist 1 See BNF for children for appropriate use and dosing in specific populations, for example hepatic impairment and renal impairment.2 The age bands apply to children of average size and, in practice, the prescriber will use the age bands in conjunction with other factors such as the severity of the condition being treated and the child s size in relation to the average size of children of the same age.3 Doxycycline is contraindicated in children under 12 years.4 If co-amoxiclav used as first choice, consult local microbiologist for advice on second choice. See what NICE says on medicines optimisation.subhead:Why we made the recommendationsSee information on choice of antibiotic and antibiotic course length.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG79", "drug": {}}}, {"category": "treatment", "id": "t8613", "name": "when to prescribe antibiotics immediately", "draggable": "true", "value": {"name": "when to prescribe antibiotics immediately", "type": "treatment related", "time": "", "intention": "", "description": "title:when to prescribe antibiotics immediatelyhead:When to prescribe antibiotics immediatelyAn immediate antibiotic prescription and/or further appropriate investigation and management should only be offered to patients (both adults and children) in the following situations: if the patient is systemically very unwell if the patient has symptoms and signs suggestive of serious illness and/or complications (particularly pneumonia, mastoiditis, peritonsillar abscess, peritonsillar cellulitis, intraorbital and intracranial complications) if the patient is at high risk of serious complications because of pre-existing comorbidity. This includes patients with significant heart, lung, renal, liver or neuromuscular disease, immunosuppression, cystic fibrosis, and young children who were born prematurely if the patient is older than 65 years with acute cough and two or more of the following criteria, or older than 80 years with acute cough and one or more of the following criteria: hospitalisation in previous year type 1 or type 2 diabetes history of congestive heart failure current use of oral glucocorticoids.For these patients, the no antibiotic prescribing strategy and the delayed antibiotic prescribing strategy should not be considered.Depending on clinical assessment of severity, patients in the following subgroups can also be considered for an immediate antibiotic prescribing strategy (in addition to a no antibiotic or a delayed antibiotic prescribing strategy): bilateral acute otitis media in children younger than 2 years acute otitis media in children with otorrhoea acute sore throat/acute pharyngitis/acute tonsillitis when three or more Centor criteria are present.See what NICE says on pneumonia and medicines optimisation.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8594", "name": "suspected impending respiratory failure", "draggable": "true", "value": {"name": "suspected impending respiratory failure", "type": "treatment related", "time": "", "intention": "", "description": "title:suspected impending respiratory failurehead:Suspected impending respiratory failureSuspect impending respiratory failure, and take appropriate action as these children may require intensive care (see NICE s recommendations on when to refer and continuous positive airway pressure if impending respiratory failure), if any of the following are present: signs of exhaustion, for example listlessness or decreased respiratory effort recurrent apnoea failure to maintain adequate oxygen saturation despite oxygen supplementation.Consider performing a chest X-ray if intensive care is being proposed for a child.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8586", "name": "measuring oxygen saturation", "draggable": "true", "value": {"name": "measuring oxygen saturation", "type": "treatment related", "time": "", "intention": "", "description": "title:measuring oxygen saturationhead:Measuring oxygen saturation Measure oxygen saturation in every child presenting with suspected bronchiolitis, including those presenting to primary care if pulse oximetry is available.Ensure healthcare professionals performing pulse oximetry are appropriately trained in its use specifically in infants and young children.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8595", "name": "alternative diagnoses", "draggable": "true", "value": {"name": "alternative diagnoses", "type": "treatment related", "time": "", "intention": "", "description": "title:alternative diagnoseshead:Alternative diagnosesConsider a diagnosis of pneumonia if the child has: high fever (over 39\u00b0C) and/or persistently focal crackles.Think about a diagnosis of viral-induced wheeze or early-onset asthma rather than bronchiolitis in older infants and young children if they have: persistent wheeze without crackles or recurrent episodic wheeze or  a personal or family history of atopy.Take into account that these conditions are unusual in children under 1 year of age.NICE is developing a guideline on diagnosis and monitoring or asthma in adults, children and young peopleSee what NICE says on: self-limiting respiratory tract and ear infections \u2013 antibiotic prescribing  fever in under 5s bacterial meningitis and meningococcal septicaemia and  early-onset neonatal infection sepsis.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8600", "name": "continuous positive airway pressure if impending respiratory failure", "draggable": "true", "value": {"name": "continuous positive airway pressure if impending respiratory failure", "type": "treatment related", "time": "", "intention": "", "description": "title:continuous positive airway pressure if impending respiratory failurehead:Continuous positive airway pressure if impending respiratory failureConsider continuous positive airway pressure in children with bronchiolitis who have impending respiratory failure (see NICE s recommendations on suspected impending respiratory failure).Consider carrying out capillary blood gas testing in children with severe worsening respiratory distress (when supplemental oxygen concentration is greater than 50%) or suspected impending respiratory failure (see NICE s recommendations on suspected impending respiratory failure).subhead:Extracorporeal membrane oxygenation (ECMO) in postneonatal childrenNICE has published interventional procedures guidance on extracorporeal membrane oxygenation (ECMO) in postneonatal children with normal arrangements for clinical governance, consent and audit. SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8599", "name": "maintaining fluid balance", "draggable": "true", "value": {"name": "maintaining fluid balance", "type": "treatment related", "time": "", "intention": "", "description": "title:maintaining fluid balancehead:Maintaining fluid balanceGive fluids by nasogastric or orogastric tube in children with bronchiolitis if they cannot take enough fluid by mouth.Give intravenous isotonic fluids (see NPSA guidance) to children who: do not tolerate nasogastric or orogastric fluids or have impending respiratory failure.See what NICE says on intravenous fluid therapy in hospital.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8626", "name": "no or delayed antibiotic prescribing", "draggable": "true", "value": {"name": "no or delayed antibiotic prescribing", "type": "treatment related", "time": "", "intention": "", "description": "title:no or delayed antibiotic prescribinghead:No or delayed antibiotic prescribingsubhead:No antibiotic prescribingA no antibiotic prescribing strategy or a delayed antibiotic prescribing strategy should be agreed for patients with the following conditions: acute otitis media acute sore throat/acute pharyngitis/acute tonsillitis common cold acute rhinosinusitis acute cough/acute bronchitis.When the no antibiotic prescribing strategy is adopted, patients should be offered: reassurance that antibiotics are not needed immediately because they are likely to make little difference to symptoms and may have side effects, for example, diarrhoea, vomiting and rash a clinical review if the condition worsens or becomes prolonged.subhead:Delayed antibiotic prescribingWhen the delayed antibiotic prescribing strategy is adopted, patients should be offered: reassurance that antibiotics are not needed immediately because they are likely to make little difference to symptoms and may have side effects, for example, diarrhoea, vomiting and rash advice about using the delayed prescription if symptoms are not starting to settle in accordance with the expected course of the illness or if a significant worsening of symptoms occurs advice about re-consulting if there is a significant worsening of symptoms despite using the delayed prescription.A delayed prescription with instructions can either be given to the patient or left at an agreed location to be collected at a later date.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.1Antimicrobial stewardshipSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8614", "name": "no or delayed antibiotic prescribing", "draggable": "true", "value": {"name": "no or delayed antibiotic prescribing", "type": "treatment related", "time": "", "intention": "", "description": "title:no or delayed antibiotic prescribinghead:No or delayed antibiotic prescribingsubhead:No antibiotic prescribingA no antibiotic prescribing strategy or a delayed antibiotic prescribing strategy should be agreed for patients with the following conditions: acute otitis media acute sore throat/acute pharyngitis/acute tonsillitis common cold acute rhinosinusitis acute cough/acute bronchitis.When the no antibiotic prescribing strategy is adopted, patients should be offered: reassurance that antibiotics are not needed immediately because they are likely to make little difference to symptoms and may have side effects, for example, diarrhoea, vomiting and rash a clinical review if the condition worsens or becomes prolonged.subhead:Delayed antibiotic prescribingWhen the delayed antibiotic prescribing strategy is adopted, patients should be offered: reassurance that antibiotics are not needed immediately because they are likely to make little difference to symptoms and may have side effects, for example, diarrhoea, vomiting and rash advice about using the delayed prescription if symptoms are not starting to settle in accordance with the expected course of the illness or if a significant worsening of symptoms occurs advice about re-consulting if there is a significant worsening of symptoms despite using the delayed prescription.A delayed prescription with instructions can either be given to the patient or left at an agreed location to be collected at a later date.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.1Antimicrobial stewardshipSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8587", "name": "when to refer", "draggable": "true", "value": {"name": "when to refer", "type": "treatment related", "time": "", "intention": "", "description": "title:when to referhead:When to refer Immediately refer children with bronchiolitis for emergency hospital care (usually by 999 ambulance) if they have any of the following: apnoea (observed or reported) child looks seriously unwell to a healthcare professional severe respiratory distress, for example grunting, marked chest recession, or a respiratory rate of over 70 breaths/minute central cyanosis persistent oxygen saturation of less than 92% when breathing air.Consider referring children with bronchiolitis to hospital if they have any of the following: a respiratory rate of over 60 breaths/minute difficulty with breastfeeding or inadequate oral fluid intake (50\u201375% of usual volume, taking account of risk factors (see NICE s recommendations on when to admit)  and using clinical judgement) clinical dehydration.When deciding whether to refer a child with bronchiolitis to secondary care, take account of the following risk factors for more severe bronchiolitis: chronic lung disease (including bronchopulmonary dysplasia) haemodynamically significant congenital heart disease age in young infants (under 3 months)  premature birth, particularly under 32 weeks neuromuscular disorders immunodeficiency.When deciding whether to refer a child to secondary care, take into account factors that might affect a carer s ability to look after a child with bronchiolitis, for example: social circumstances the skill and confidence of the carer in looking after a child with bronchiolitis at home confidence in being able to spot red flag symptoms (see NICE s recommendations on red flags in safety information when looking after a child at home) distance to healthcare in case of deterioration.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8601", "name": "blood gas testing", "draggable": "true", "value": {"name": "blood gas testing", "type": "treatment related", "time": "", "intention": "", "description": "title:blood gas testinghead:Blood gas testingDo not routinely carry out blood gas testing in children with bronchiolitis.Consider carrying out capillary blood gas testing in children with severe worsening respiratory distress (when supplemental oxygen concentration is greater than 50%) or suspected impending respiratory failure (see NICE s recommendations on suspected impending respiratory failure).SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8602", "name": "when to discharge patient", "draggable": "true", "value": {"name": "when to discharge patient", "type": "treatment related", "time": "", "intention": "", "description": "title:when to discharge patienthead:When to dischargeWhen deciding on the timing of discharge for children admitted to hospital, make sure that the child: is clinically stable is taking adequate oral fluids has maintained oxygen saturation over 92% in air for 4 hours, including a period of sleep.When deciding whether to discharge a child, take into account factors that might affect a carer s ability to look after a child with bronchiolitis, for example: social circumstances the skill and confidence of the carer in looking after a child with bronchiolitis at home confidence in being able to spot red flag symptoms (see NICE s recommendations on safety information when looking after a child at home) distance to healthcare in case of deterioration.Provide parents or carers with key safety information (see NICE s recommendations on safety information when looking after a child at home) when the child is discharged.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8627", "name": "address patients or parents and or carers concerns and expectations", "draggable": "true", "value": {"name": "address patients or parents and or carers concerns and expectations", "type": "information and support", "time": "", "intention": "", "description": "title:address patients or parents and or carers concerns and expectationshead:Address patients  or parents  and/or carers  concerns and expectationsPatients  or parents /carers  concerns and expectations should be determined and addressed when agreeing the use of the three antibiotic prescribing strategies (no prescribing, delayed prescribing and immediate prescribing).SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8615", "name": "address patients or parents and or carers concerns and expectations", "draggable": "true", "value": {"name": "address patients or parents and or carers concerns and expectations", "type": "information and support", "time": "", "intention": "", "description": "title:address patients or parents and or carers concerns and expectationshead:Address patients  or parents  and/or carers  concerns and expectationsPatients  or parents /carers  concerns and expectations should be determined and addressed when agreeing the use of the three antibiotic prescribing strategies (no prescribing, delayed prescribing and immediate prescribing).SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8588", "name": "assessment in hospital", "draggable": "true", "value": {"name": "assessment in hospital", "type": "treatment related", "time": "", "intention": "", "description": "title:assessment in hospitalhead:Assessment in hospitalMeasure oxygen saturation using pulse oximetry in every child presenting to secondary care with clinical evidence of bronchiolitis.Clinically assess the hydration status of children with bronchiolitis. When assessing a child in a secondary care setting, admit them to hospital if they have any of the following: apnoea (observed or reported) persistent oxygen saturation of less than 92% when breathing air inadequate oral fluid intake (50\u201375% of usual volume, taking account of risk factors (see NICE s recommendations on when to admit) and using clinical judgement)  persisting severe respiratory distress, for example grunting, marked chest recession, or a respiratory rate of over 70 breaths/minute.Do not routinely perform blood tests in the assessment of a child with bronchiolitis.Do not perform a chest X-ray in children with bronchiolitis, because changes on X-ray may mimic pneumonia and should not be used to determine the need for antibiotics.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8589", "name": "when to admit", "draggable": "true", "value": {"name": "when to admit", "type": "treatment related", "time": "", "intention": "", "description": "title:when to admithead:When to admit When deciding whether to admit a child, take into account factors that might affect a carer s ability to look after a child with bronchiolitis, for example: social circumstances the skill and confidence of the carer in looking after a child with bronchiolitis at home confidence in being able to spot red flag symptoms (see NICE s recommendations on red flags in safety information when looking after a child at home) distance to healthcare in case of deterioration.When deciding whether to admit a child with bronchiolitis, take account of the following risk factors for more severe bronchiolitis: chronic lung disease (including bronchopulmonary dysplasia) haemodynamically significant congenital heart disease age in young infants (under 3 months)  premature birth, particularly under 32 weeks neuromuscular disorders immunodeficiency.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8603", "name": "safety information when looking after a child at home", "draggable": "true", "value": {"name": "safety information when looking after a child at home", "type": "treatment related", "time": "", "intention": "", "description": "title:safety information when looking after a child at home", "drug": {}}}, {"category": "treatment", "id": "t8628", "name": "patient advice and information", "draggable": "true", "value": {"name": "patient advice and information", "type": "treatment related", "time": "", "intention": "", "description": "title:patient advice and informationhead:Patient advice and informationFor all antibiotic prescribing strategies, patients should be given:  advice about the usual natural history of the illness, including the average total length of the illness (before and after seeing the doctor): acute otitis media: 4 days acute sore throat/acute pharyngitis/acute tonsillitis: 1 week common cold: 1.5 weeks acute rhinosinusitis: 2.5 weeks acute cough/acute bronchitis: 3 weeks advice about managing symptoms, including fever (particularly analgesics and antipyretics). For information about fever in children younger than 5 years, see what NICE says on fever in under 5s.NICE has written information for the public on respiratory tract infections (self-limiting): prescribing antibiotics.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8616", "name": "patient advice and information", "draggable": "true", "value": {"name": "patient advice and information", "type": "treatment related", "time": "", "intention": "", "description": "title:patient advice and informationhead:Patient advice and informationFor all antibiotic prescribing strategies, patients should be given:  advice about the usual natural history of the illness, including the average total length of the illness (before and after seeing the doctor): acute otitis media: 4 days acute sore throat/acute pharyngitis/acute tonsillitis: 1 week common cold: 1.5 weeks acute rhinosinusitis: 2.5 weeks acute cough/acute bronchitis: 3 weeks advice about managing symptoms, including fever (particularly analgesics and antipyretics). For information about fever in children younger than 5 years, see what NICE says on fever in under 5s.NICE has written information for the public on respiratory tract infections (self-limiting): prescribing antibiotics.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG69", "drug": {}}}, {"category": "treatment", "id": "t8592", "name": "child admitted to hospital", "draggable": "true", "value": {"name": "child admitted to hospital", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:child admitted to hospital", "drug": {}}}, {"category": "treatment", "id": "t8590", "name": "child not admitted to hospital", "draggable": "true", "value": {"name": "child not admitted to hospital", "type": "treatment related", "time": "", "intention": "", "description": "title:child not admitted to hospitalhead:Child not admitted to hospitalProvide parents or carers with key safety information (see NICE s recommendations on safety information when looking after a child at home) if the child is not admitted.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG9", "drug": {}}}, {"category": "treatment", "id": "t8629", "name": "otitis media", "draggable": "true", "value": {"name": "otitis media", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:otitis mediahead:Otitis mediaNICE is developing a guideline on otitis media (acute): antimicrobial prescribing.See what NICE says on surgical management of otitis media with effusion in children.", "drug": {}}}, {"category": "treatment", "id": "t8630", "name": "sinusitis", "draggable": "true", "value": {"name": "sinusitis", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:sinusitis", "drug": {}}}, {"category": "treatment", "id": "t8617", "name": "otitis media", "draggable": "true", "value": {"name": "otitis media", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:otitis media", "drug": {}}}, {"category": "treatment", "id": "t8618", "name": "sinusitis", "draggable": "true", "value": {"name": "sinusitis", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:sinusitis", "drug": {}}}, {"category": "treatment", "id": "t8593", "name": "management in hospital", "draggable": "true", "value": {"name": "management in hospital", "type": "treatment related", "time": "", "intention": "", "description": "title:management in hospital", "drug": {}}}, {"category": "treatment", "id": "t8591", "name": "safety information when looking after a child at home", "draggable": "true", "value": {"name": "safety information when looking after a child at home", "type": "treatment related", "time": "", "intention": "", "description": "title:safety information when looking after a child at home", "drug": {}}}, {"category": "drug", "id": "d346", "name": "ibuprofen", "draggable": "true", "value": {"name": "ibuprofen", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d341", "name": "hypertonic saline", "draggable": "true", "value": {"name": "hypertonic saline", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d15", "name": "adrenalin", "draggable": "true", "value": {"name": "adrenalin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d372", "name": "ipratropium bromide", "draggable": "true", "value": {"name": "ipratropium bromide", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d263", "name": "erythromycin", "draggable": "true", "value": {"name": "erythromycin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d37", "name": "amoxicillin", "draggable": "true", "value": {"name": "amoxicillin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d297", "name": "fluticasone", "draggable": "true", "value": {"name": "fluticasone", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d166", "name": "clarithromycin", "draggable": "true", "value": {"name": "clarithromycin", "time": "None", "period": "None", "dosage": "None"}}, {"category": "drug", "id": "d235", "name": "doxycycline", "draggable": "true", "value": {"name": "doxycycline", "time": "None", "period": "None", "dosage": "None"}}]}